Wilfried E. E. Eberhardt MDDepartment of Medical Oncology, West German Cancer Center, Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany
Recent Contributions to PracticeUpdate:
- Combination Immunotherapy in the First Line Treatment of NSCLC
- Updates on Lung Cancer With a Driver Mutation
- A New Standard of Care in Lung Cancer?
- Lung Cancer Studies at ASCO 2018
- First-Line Treatment of Advanced NSCLC Without Driver Mutations—Is the Standard of Care Rapidly Changing?
- Practical Considerations in the Management of NSCLC
- NSCLC Trial Review From ESMO 2017
- Critical Issues in Thoracic Oncology
- ASCO 2017: Abstract Recommendations From Dr. Wilfried Eberhardt—Lung Cancer